It can be seen that in terms of anti-inflammatory treatment of sepsis, the therapeutic window of anti-HMGB1 may be wider compared with the intervention treatment of some early inflammatory factors (such as IL-6 and TNF-α). The gene discussed is IL6; the disease is Sepsis.